European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.12. Elderly (specific problems).
A. Because renal transplantation can extend the duration and quality of life in elderly patients (age 60-70 years) with end-stage renal disease, transplantation should be considered in all patients, particularly if special programmes and preparations are applied. B. In elderly kidney transplant recipients, immunosuppression has to be adapted to avoid both rejections and adverse effects. C. Accurate diagnosis and aggressive treatment of cardiovascular disease in elderly recipients are recommended because of the high number of deaths with functioning grafts. D. The high risk of concomitant diseases, such as diabetes mellitus, bone disease and malignancies, needs special consideration.
D000367:Age Factors; D000368:Aged; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D014019:Tissue Donors
D007166:Immunosuppressive Agents